Unicycive investors get lawsuit deadline reminder
Rosen Law Firm said investors who bought Unicycive Therapeutics shares in a specified class period have until Nov. 2, 2026, to seek lead-plaintiff status in an already filed securities lawsuit.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded, newest first. End of these results.
Unicycive Therapeutics (UNCY) securities class action deadline set for Nov 2, 2026
Robbins LLP Urges UNCY Stockholders Who Lost Money Investing in Unicycive Therapeutics, Inc. to Contact the Firm for Information About Leading the Class Action
For best results when printing this announcement, please click on link below: Robbins LLP Urges UNCY Stockholders Who Lost Money Investing in Unicycive Therapeutics, Inc. to Contact the Firm for Information About Leading the Class Action Shareholder rights law firm Robbins LLP ( ) reminds investors that a class action